Are you willing to give up your EPI pen, and die, so the CEO can make $98 million?
EpiPen maker Mylan is racing to put down a revolt from shareholders outraged by a $ 98 million pay package for its former CEO.
Institutional Shareholder Services, a shareholder advisory firm, took the rare step of urging investors to oust all of Mylan’s existing directors.
ISS chastised the Mylan board for “multiple egregious pay decisions” and a failure to heed “warning signs” ahead of last summer’s scandal over EpiPen pricing.
- xg6Lv 73 years agoFavorite Answer
No, but I'm also not a conservative
- 3 years ago
Are you willing to understand that it takens decades and billions of dollars to research these medications. And shortly after they get to the market, they lose their patent.
- Anonymous3 years ago
CEO won't make anything if no one buys the product